IIT Madras Develops Affordable, Minimally Invasive Glucose Monitoring Device for Diabetes Patients
Researchers at the Indian Institute of Technology Madras have developed and patented a low-cost, user-friendly glucose monitoring device designed to make diabetes management more comfortable and accessible.Led by Prof. Parasuraman Swaminathan from the Electronic Materials and Thin Films Lab, the team has created a minimally invasive Continuous Glucose Monitoring (CGM) system that combines reusable electronics, a low-power display, and a disposable microneedle sensor patch.
According to the ICMR–INDIAB Study (2023), India has 10.1 crore diabetes patients, highlighting the urgent need for affordable monitoring solutions. Traditional methods like Self-Monitoring of Blood Glucose (SMBG) require frequent finger pricks, while existing CGM systems are often expensive and depend on smartphones or external readers.
The IIT Madras innovation aims to overcome these challenges. The device directly displays glucose readings on the patch itself using a patented electro-thermochromic display that consumes power only when updating readings. This allows users to check their glucose levels instantly—without phones, separate devices, or repeated invasive sampling.
Prof. Swaminathan explained that the real goal was to make research impactful at a human level: “The real measure of success is when an idea steps out of the lab and starts making a tangible difference. This device could spare patients from multiple daily pricks and help them manage diabetes more effectively.”
Mr. L. Balamurugan, an MS Entrepreneurship scholar at IIT Madras working on the project, added that such innovations can transform healthcare habits: “By making glucose monitoring painless and affordable, people are encouraged to check regularly, act early, and prevent complications. It also supports India’s self-reliance in medical technology.”
Path to Commercialisation
The research team has adopted a three-track approach to bring the device to market:
- Start-up Commercialisation: A start-up has been formed to refine the product, conduct clinical trials, and commercialise it through IIT Madras Research Park.
- Technology Transfer: Talks are underway with medical device manufacturers to scale production through industrial licensing.
- Strategic Partnerships: Global and domestic organisations have shown interest in future collaborations.
Technical Progress and Next Steps
The display module prototypes have been successfully tested in the lab and are protected by two Indian patents and one international PCT application. Bench tests confirm the system’s accuracy, stability, and energy efficiency.Next milestones include clinical validation, manufacturing readiness, regulatory clearance, and real-world reliability testing.
This innovation holds promise for reducing healthcare costs, improving patient comfort, and strengthening India’s position in indigenous medical device development—potentially transforming diabetes management for millions.
